Article
CAR NK Cells: The Future Is Now
2023-01-17
Abstract excerpt
Chimeric antigen receptor (CAR) T cell therapy has been a great success in CD19+ hematological diseases. Natural killer (NK) CAR cells offer an alternative to CAR T cells with an intrinsic potential for universal off-the-shelf cell therapeutics. The choice of cell type and the choice of CAR are both relevant for the feasibility, effectivity, engraftment, persistence, side effects, and safety of the cell therapy. U...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 08005938-3fd0-5305-87cb-55601111eb24
- DOI
- 10.1146/annurev-cancerbio-061521-082320
